Page 301 - Tata_Chemicals_yearly-reports-2020-2021
P. 301

Integrated Report   Statutory Reports  Financial Statements
              1-59                60-146             Consolidated



                   ` in crore  %   holding  100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   50.06   65.77   100.00   100.00   100.00   100.00   100.00   100.00   100.00   100.00   50.00   100.00

                       Dividend    -      -      -      -      -      -      -      -      -      23.17    -      -      148.17    152.66    95.04    -      -      -      292.44    -      2.92    48.62    -      -      -      -      -      -      -      -      -      132.05    -



                      Profit   After   Taxation    80.40    (13.92)   (156.96)   (165.22)   (148.22)   (92.90)   20.28    12.23    -      (0.90)   -      52.39    117.57    115.76    (107.91)   -      -      -      1.53    (0.26)   2.92    228.68    (0.10)   14.15    -      -      -      -      -      -      0.26    132.87    (0.04)
              Statement pursuant to first proviso to sub-section (3) of section 129 of the Companies Act 2013, read with rule 5 of Companies
                (Accounts) Rules, 2014 in the prescribed Form AOC-1 relating to subsidiary and joint venture companies as on March 31, 2021
                      Provision   for   Taxation    6.07    -      -      -      6.70    9.79    -      4.68    -      -      -      -      -      (10.24)   (11.16)   -      -      -      -      -      -      74.93    -      0.14    -      -      -      -      -      -      -      -      -



                      Profit   Before   Taxation    86.47    (13.92)   (156.96)   (165.22)   (141.52)   (83.11)   20.28    16.91    -      (0.90)   -      52.39    117.57    105.52    (119.07)   -      -      -      1.53    (0.26)   2.92    303.61    (0.10)   14.29    -      -      -      -      -      -      0.26    132.87    (0.04)

                       Turnover    771.74    -      -      -      -      922.20    406.56    102.66    -      -      -      468.49    -      -      23.58    -      -      -      2,648.46    -      -      2,429.43    -      362.46    -      -      -      -      -      -      -      408.91    21.60


                       Investments    5,276.98    43.87    490.01   *   -      -      -      -      -      -      -      -      5,533.82    8,831.42    1,700.12    -      -      -      -      -      -      283.48    -      7.72    4.03    4.03    -      -      -      -      1.48    -      1.38




                       Total   Liabilities    1,898.84    1,337.34    476.82    1,587.79    -      1,866.12    553.35    6.75    -      -      -      280.36    0.21    1,461.51    2,096.57    -      -      -      1,091.84    -      -      996.05    0.03    637.85    -      0.03    0.06    -      -      -      -      35.49    6.59


                       Total   Assets    5,754.46    49.07    490.01    969.08    785.38    942.69    371.51    55.38    *    1.51    0.01    520.55    5,621.77    8,859.49    3,221.67    -      0.01    *    2,717.70    1.18    -      2,587.42    1.22    845.94    4.06    11.89    -      *    *    *    19.79    45.33    6.63

                       Reserves    (507.13)   (2,276.20)   (399.06)   (1,030.96)   (57.08)   (1,296.61)   (504.81)   47.79    -      1.51    -      240.19    271.47    7,397.98    1,125.10    *    -      -      1,625.86    1.18    -      1,571.92    (5.64)   208.09    2.65    11.86    (0.07)   -      -      -      12.11    9.84    (2.51) @ During the year, PT Metahelix Life Sciences Indonesia, a subsidiary of the Company, received approval for the cancellation of its


                       Share   Capital    4,362.75    987.93    412.25    412.25    842.46    373.18    322.97    0.84    *    *    0.01    -      5,350.09    *    *   *   0.01    *    -      -      -      19.45    6.83    *    1.41    *    0.01    *    *    *    7.68    -      2.55  license w.e.f March 19, 2021. Further, an application for cancellation of its Tax Identification Number has been made and the approval for the same is awaited.

                      Exchange   rate  73.11   73.11   100.75   100.75   100.75   100.75   73.11   4.95   100.75   100.75   0.67   100.75   73.11   73.11   73.11   73.11   73.11   73.11   73.11   73.11   73.11   1.00   0.01   100.75   100.75   100.75   100.75   100.75   100.75   100.75   100.75   73.11   1.00  The Financial Statements of subsidiaries are converted into Indian Rupees on the basis of exchange rate as on closing day of the financial year.



                      Reporting   Currency  USD  USD  GBP  GBP  GBP  GBP  USD  ZAR  GBP  GBP  KSH  GBP  USD  USD  USD  USD  USD  USD  USD  USD  USD  INR  Rupiah  GBP  GBP  GBP  GBP  GBP  GBP  GBP  GBP  USD  INR


                      Date of acqusition   / incorporation  October 23, 2005  November 01, 2005  December 14, 2010  December 07, 2010  October 22, 2005  October 22, 2005  February 28, 2005  April 09, 1996  October 22, 2005  October 22, 2005  February 28, 2005  June 13, 2013  December 04, 2007  January 30, 2008  March 26, 2008  August 22, 2014  March 26, 2008  March 26, 2008  March 26, 2008  March 26, 2008  March 26, 2008  November 09, 2009  May 19, 2016  January 18, 2








                       Name of the Subsidiary Company     Tata Chemicals International Pte. Limited  Homefield Pvt. UK Limited  TCE Group Limited   Natrium Holdings Limited  Brunner Mond Group Limited  Tata Chemicals Europe Limited  Tata Chemicals Magadi Limited Tata Chemicals South Africa (Pty) Limited Northwich Resource Management Limited Tata Chemicals Africa Holdings Limited  Magadi Railway Company Limited   Winnington CHP Limited  Gusiute Holdings (UK) Limited  V











                      Sr.   No.  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  TCSAP LLC  21  22  23  24  25  26  27  28  29  30  31  ALCAD  32  33  Notes:  1.   2.   3.   4.  5.


                                                                                                           299
   296   297   298   299   300   301   302   303   304   305   306